Pharmaceutical Sciences Master |
Kernfächer I |
Nummer | Titel | Typ | ECTS | Umfang | Dozierende |
---|
535-0030-00L | Therapeutic Proteins | O | 3 KP | 3G | |
535-0030-00 G | Therapeutic Proteins | | | 3 Std. | | C. Halin Winter,
D. Neri |
535-0041-00L | Pharmacology and Toxicology III | O | 2 KP | 2G | |
535-0041-00 G | Pharmacology and Toxicology III | | | 2 Std. | | M. Detmar,
U. Quitterer |
535-0050-00L | Pharmacoepidemiology and Drug Safety | O | 3 KP | 2G | |
535-0050-00 G | Pharmacoepidemiology and Drug Safety | | | 2 Std. | | S. Russmann |
535-0546-00L | Patente | O | 1 KP | 1V | |
535-0546-00 V | Patente | | | 1 Std. | | A. Koepf,
P. Pliska |
511-0000-00L | Drug Discovery and Development | O | 2 KP | 2G | |
511-0000-00 G | Drug Discovery and Development
Bewilligung der Dozierenden für alle Studierenden notwendig.
| | | 24s Std. | | U. Thibaut,
J. Hall |
511-0007-00L | Scientific Writing and Presenting Number of participants limited to 24. | O | 2 KP | 2G | |
511-0007-00 G | Scientific Writing and Presenting
Bewilligung der Dozierenden für alle Studierenden notwendig.
| | | 2 Std. | | G. Schneider,
J. Dolenc,
J. A. Hiss,
J.‑C. Leroux,
O. Renn,
J. Schnabl |
|
Wahlfächer I |
Nummer | Titel | Typ | ECTS | Umfang | Dozierende |
---|
535-0011-00L | Drug Seminar Die Belegung dieser Lerneinheit ist nur für Studierende möglich, die im Master Pharmazie oder im Master Pharmaceutical Sciences eingeschrieben sind. | W | 5 KP | 9S | |
535-0011-00 S | Drug Seminar
Bewilligung der Dozierenden für alle Studierenden notwendig.
Presentation on 2nd and 3rd of November, HIT E 51 | | | 125s Std. | | C. Halin Winter,
K.‑H. Altmann,
S. M. Ametamey,
M. Detmar,
B. A. Gander,
J. Hall,
S.‑D. Krämer,
J.‑C. Leroux,
C. Müller,
D. Neri,
V. I. Otto,
U. Quitterer,
R. Schibli,
G. Schneider,
C. Steuer,
H. U. Zeilhofer |
511-1001-00L | Biopharmacy (Crash Course) Obligatory course if assigned by the Admission committee. | E- | 2 KP | 1S | |
511-1001-00 S | Biopharmacy (Crash Course)
| | | 14s Std. | | S.‑D. Krämer |
511-1002-00L | Pharmaceutical Analytics and Pharmacopeia (Crash Course) Obligatory course if assigned by the Admission committee. | E- | 2 KP | 1S | |
511-1002-00 S | Pharmaceutical Analytics and Pharmacopeia (Crash Course)
Dates: September 21, October 5, 12, 26 and November 1 | | | 10s Std. | | C. Steuer |
511-1003-00L | Gene Technology (Crash Course) Obligatory course if assigned by the Admission committee. | E- | 1 KP | 1S | |
511-1003-00 S | Gene Technology (Crash Course)
Starts on 20 September | | | 12s Std. | | J. Scheuermann |
535-0423-00L | Drug Delivery and Drug Targeting | W | 2 KP | 1.5V | |
535-0423-00 V | Drug Delivery and Drug Targeting | | | 1.5 Std. | | J.‑C. Leroux,
A. Spyrogianni Roveri |
535-0250-00L | Biotransformation of Drugs and Xenobiotics | W | 1 KP | 1V | |
535-0250-00 V | Biotransformation of Drugs and Xenobiotics | | | 1 Std. | | S.‑D. Krämer |
535-0015-00L | Geschichte der Pharmazie | W | 1 KP | 1V | |
535-0015-00 V | Geschichte der Pharmazie | | | 1 Std. | | M. Fankhauser |
535-0344-00L | Von Ethnopharmazie zu molekularer Pharmakognosie | W | 1 KP | 1V | |
535-0344-00 V | Von Ethnopharmazie zu molekularer Pharmakognosie | | | 1 Std. | | B. Frei Haller,
J. Gertsch |
535-0310-00L | Glycobiology in Drug Development | W | 1 KP | 1V | |
535-0310-00 V | Glycobiology in Drug Development | | | 1 Std. | | V. I. Otto |
535-0300-00L | Molecular Mechanisms of Drug Actions and Targets Maximale Teilnehmerzahl: 24 | W | 2 KP | 1V | |
535-0300-00 V | Molecular Mechanisms of Drug Actions and Targets | | | 1 Std. | | V. I. Otto,
J. Scheuermann |
535-0021-00L | Vitamine in der Vorsorge und Therapie | W | 1 KP | 1V | |
535-0021-00 V | Vitamine in der Vorsorge und Therapie | | | 1 Std. | | C. Müller |
535-0360-00L | Rationale Phytotherapie an ausgewählten Beispielen | W | 1 KP | 1V | |
535-0360-00 V | Rationale Phytotherapie an ausgewählten Beispielen
Beginnt am 27.9.2017 | | | 1 Std. | | J. Drewe,
K. Berger Büter |
535-0137-00L | Clinical Chemistry II | W | 1 KP | 1V | |
535-0137-00 V | Clinical Chemistry II | | | 1 Std. | | M. Hersberger |
535-0022-00L | Computer-Assisted Drug Design | W | 1 KP | 1V | |
535-0022-00 V | Computer-Assisted Drug Design | | | 1 Std. | | G. Schneider |